Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage

Nucleic Acids Research

Volumn 37, Issue 9, 2009, Pages 2962-2973

  Logan, Ian R ^a   Mcneill, Hesta V ^a   Cook, Susan ^a   Lu, Xiaohong ^a   Meek, David W ^b   Fuller Pace, Frances V ^c   Lunec, John ^a   Robson, Craig N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; CHECKPOINT KINASE 1; CIS ACTING ELEMENT; HEAT SHOCK TRANSCRIPTION FACTOR 1; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DNA DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL CYCLE; CELL LINE; DNA DAMAGE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 66249126506     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp180     Document Type: Article

References (72)

1. Zhou, B.B. and Elledge, S.J. (2000) The DNA damage response: Putting checkpoints in perspective. Nature, 408, 433-439.
2. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W. and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science, 282, 1497-1501.
3. el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
4. Nakano, K. and Vousden, K.H. (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell, 7, 683-694.
5. Yu, J., Zhang, L., Hwang, P.M., Kinzler, K.W. and Vogelstein, B. (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell, 7, 673-682.
6. Smith, M.L., Chen, I.T., Zhan, Q., Bae, I., Chen, C.Y., Gilmer, T.M., Kastan, M.B., O'Connor, P.M. and Fornace, A.J. Jr (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 266, 1376-1380.
7. Olivier, M., Eeles, R., Hollstein, M., Khan, M.A., Harris, C.C. and Hainaut, P. (2002) The IARC TP53 database: New online mutation analysis and recommendations to users. Hum. Mutat., 19, 607-614.
8. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
9. Momand, J., Jung, D., Wilczynski, S. and Niland, J. (1998) The MDM2 gene amplification database. Nucleic Acids Res., 26, 3453-3459.
10. Honda, R., Tanaka, H. and Yasuda, H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett., 420 25-27.
11. Shieh, S.Y., Ikeda, M., Taya, Y. and Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 91, 325-334.
12. Siliciano, J.D., Canman, C.E., Taya, Y., Sakaguchi, K., Appella, E. and Kastan, M.B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev., 11, 3471-3481.
13. Meek, D.W. (2002) p53 Induction: Phosphorylation sites cooperate in regulating. Cancer Biol. Ther., 1, 284-286.
14. Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90 595-606.
15. Hardcastle, I.R., Ahmed, S.U., Atkins, H., Calvert, A.H., Curtin, N.J., Farnie, G., Golding, B.T., Griffin, R.J., Guyenne, S., Hutton, C. et al. (2005) Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. Bioorg. Med. Chem. Lett., 15, 1515-1520.
16. Vassilev, L.T., Vu, B.T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C. et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science, 303, 844-848.
17. Wang, W., Kim, S.H. and El-Deiry, W.S. (2006) Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts. Proc. Natl Acad. Sci. USA, 103, 11003-11008.
18. Yang, Y., Ludwig, R.L., Jensen, J.P., Pierre, S.A., Medaglia, M.V., Davydov, I.V., Safiran, Y.J., Oberoi, P., Kenten, J.H., Phillips, A.C. et al. (2005) Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell, 7 547-559.
19. Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B.T., Qing, W., Packman, K. et al. (2006) Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy. Proc. Natl Acad. Sci. USA, 103, 1888-1893.
20. Logan, I.R., McNeill, H.V., Cook, S., Lu, X., Lunec, J. and Robson, C.N. (2007) Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells. Prostate, 67, 900-906.
21. Gu, W., Shi, X.L. and Roeder, R.G. (1997) Synergistic activation of transcription by CBP and p53. Nature, 387, 819-823.
22. An, W., Kim, J. and Roeder, R.G. (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell, 117, 735-748.
23. Chuikov, S., Kurash, J.K., Wilson, J.R., Xiao, B., Justin, N., Ivanov, G.S., McKinney, K., Tempst, P., Prives, C., Gamblin, S.J. et al. (2004) Regulation of p53 activity through lysine methylation. Nature 432, 353-360.
24. Shikama, N., Lee, C.W., France, S., Delavaine, L., Lyon, J., Krstic-Demonacos, M. and La Thangue, N.B. (1999) A novel cofactor for p300 that regulates the p53 response. Mol. Cell, 4, 365-376.
25. Samuels-Lev, Y., O'Connor, D.J., Bergamaschi, D., Trigiante, G., Hsieh, J.K., Zhong, S., Campargue, I., Naumovski, L., Crook, T. and Lu, X. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell, 8, 781-794.
26. Prives, C. and Hall, P.A. (1999) The p53 pathway. J. Pathol., 187, 112-126.
27. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
28. Enari, M., Ohmori, K., Kitabayashi, I. and Taya, Y. (2006) Requirement of clathrin heavy chain for p53-mediated transcription. Genes Dev. 20, 1087-1099.
29. Bourdon, J.C., Laurenzi, V.D., Melino, G. and Lane, D. (2003) p53: 25 years of research and more questions to answer. Cell Death Differ. 10, 397-399.
30. Zheng, H., You, H., Zhou, X.Z., Murray, S.A., Uchida, T., Wulf, G., Gu, L., Tang, X., Lu, K.P. and Xiao, Z.X. (2002) The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature, 419, 849-853.
31. Morimoto, R.I. (1998) Regulation of the heat shock transcriptional response: Cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev., 12, 3788-3796.
32. Jolly, C. and Morimoto, R.I. (2000) Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl Cancer Inst., 92, 1564-1572.
33. Zou, J., Guo, Y., Guettouche, T., Smith, D.F. and Voellmy, R. (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94, 471-480.
34. Fernandes, M., Xiao, H. and Lis, J.T. (1995) Binding of heat shock factor to and transcriptional activation of heat shock genes in Drosophila. Nucleic Acids Res., 23, 4799-4804.
35. Green, M., Schuetz, T.J., Sullivan, E.K. and Kingston, R.E. (1995) A heat shock-responsive domain of human HSF1 that regulates transcription activation domain function. Mol. Cell Biol., 15, 3354-3362.
36. Chen, Y., Barlev, N.A., Westergaard, O. and Jakobsen, B.K. (1993) Identification of the C-terminal activator domain in yeast heat shock factor: Independent control of transient and sustained transcriptional activity. EMBO J., 12, 5007-5018.
37. Dai, Q., Zhang, C., Wu, Y., McDonough, H., Whaley, R.A., Godfrey, V., Li, H.H., Madamanchi, N., Xu, W., Neckers, L. et al. (2003) CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J., 22, 5446-5458.
38. Boellmann, F., Guettouche, T., Guo, Y., Fenna, M., Mnayer, L. and Voellmy, R. (2004) DAXX interacts with heat shock factor 1 during stress activation and enhances its transcriptional activity. Proc. Natl Acad. Sci. USA, 101, 4100-4105.
39. Abravaya, K., Myers, M.P., Murphy, S.P. and Morimoto, R.I. (1992) The human heat shock protein hsp70 interacts with HSF, the transcription factor that regulates heat shock gene expression. Genes Dev., 6 1153-1164.
40. Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., Fehrenbacher, N., Lademann, U., Hoyer-Hansen, M., Weber, E., Multhoff, G., Rohde, M. and Jaattela, M. (2004) Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med., 200, 425-435.
41. Westerheide, S.D., Kawahara, T.L., Orton, K. and Morimoto, R.I. (2006) Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J. Biol. Chem., 281, 9616-9622.
42. McMillan, D.R., Xiao, X., Shao, L., Graves, K. and Benjamin, I.J. (1998) Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J. Biol. Chem., 273, 7523-7528.
43. Jedlicka, P., Mortin, M.A. and Wu, C. (1997) Multiple functions of Drosophila heat shock transcription factor in vivo. EMBO J., 16 2452-2462.
44. Min, J.N., Huang, L., Zimonjic, D.B., Moskophidis, D. and Mivechi, N.F. (2007) Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene, 26, 5086-5097.
45. Dai, C., Whitesell, L., Rogers, A.B. and Lindquist, S. (2007) Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130, 1005-1018.
46. Zylicz, M., King, F.W. and Wawrzynow, A. (2001) Hsp70 interactions with the p53 tumour suppressor protein. EMBO J., 20, 4634-4638.
47. King, F.W., Wawrzynow, A., Hohfeld, J. and Zylicz, M. (2001) Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J., 20, 6297-6305.
48. Walerych, D., Kudla, G., Gutkowska, M., Wawrzynow, B., Muller, L., King, F.W., Helwak, A., Boros, J., Zylicz, A. and Zylicz, M. (2004) Hsp90 chaperones wild-type p53 tumor suppressor protein. J. Biol. Chem., 279, 48836-48845.
49. Logan, I.R., Sapountzi, V., Gaughan, L., Neal, D.E. and Robson, C.N. (2004) Control of human PIRH2 protein stability: Involvement of TIP60 and the proteosome. J. Biol. Chem., 279, 11696-11704.
50. Gaughan, L., Logan, I.R., Neal, D.E. and Robson, C.N. (2005) Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res., 33, 13-26.
51. Logan, I.R., Gaughan, L., McCracken, S.R., Sapountzi, V., Leung, H.Y. and Robson, C.N. (2006) Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer. Mol. Cell Biol., 26, 6502-6510.
52. Brummelkamp, T.R., Bernards, R. and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-553.
53. Pirkkala, L., Nykanen, P. and Sistonen, L. (2001) Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J., 15, 1118-1131.
54. Vujanac, M., Fenaroli, A. and Zimarino, V. (2005) Constitutive nuclear import and stress-regulated nucleocytoplasmic shuttling of mammalian heat-shock factor 1. Traffic, 6, 214-229.
55. Yao, J., Munson, K.M., Webb, W.W. and Lis, J.T. Dynamics of heat shock factor association with native gene loci in living cells. Nature, 442, 1050-1053.
56. Kaeser, M.D. and Iggo, R.D. (2002) Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl Acad. Sci. USA, 99, 95-100.
57. Luft, J.C., Benjamin, I.J., Mestril, R. and Dix, D.J. (2001) Heat shock factor 1-mediated thermotolerance prevents cell death and results in G2/ M cell cycle arrest. Cell Stress Chaperones, 6, 326-336.
58. Bruno, T., De Nicola, F., Iezzi, S., Lecis, D., D'Angelo, C., Di Padova, M., Corbi, N., Dimiziani, L., Zannini, L., Jekimovs, C. et al. (2006) Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell, 10, 473-486.
59. Bates, G.J., Nicol, S.M., Wilson, B.J., Jacobs, A.M., Bourdon, J.C., Wardrop, J., Gregory, D.J., Lane, D.P., Perkins, N.D. and Fuller-Pace, F.V. (2005) The DEAD box protein p68: A novel transcriptional coactivator of the p53 tumour suppressor. EMBO J., 24, 543-553.
60. Shieh, S.Y., Ahn, J., Tamai, K., Taya, Y. and Prives, C. (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev., 14, 289-300.
61. Gomes, N.P., Bjerke, G., Llorente, B., Szostek, S.A., Emerson, B.M. and Espinosa, J.M. (2006) Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev., 20, 601-612.
62. Espinosa, J.M., Verdun, R.E. and Emerson, B.M. (2003) p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol. Cell, 12, 1015-1027.
63. Ashcroft, M., Taya, Y. and Vousden, K.H. (2000) Stress signals utilize multiple pathways to stabilize p53. Mol. Cell Biol., 20, 3224-3233.
64. Rossi, A., Ciafre, S., Balsamo, M., Pierimarchi, P. and Santoro, M.G. (2006) Targeting the heat shock factor 1 by RNA interference: A potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res., 66, 7678-7685.
65. Canman, C.E., Lim, D.S., Cimprich, K.A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M.B. and Siliciano, J.D. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science, 281, 1677-1679.
66. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C.W., Chessa, L., Smorodinsky, N.I., Prives, C., Reiss, Y., Shiloh, Y. et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science, 281, 1674-1677.
67. Tibbetts, R.S., Brumbaugh, K.M., Williams, J.M., Sarkaria, J.N., Cliby, W.A., Shieh, S.Y., Taya, Y., Prives, C. and Abraham, R.T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157.
68. Lees-Miller, S.P., Chen, Y.R. and Anderson, C.W. (1990) Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell Biol., 10, 6472-6481.
69. Meek, D.W., Simon, S., Kikkawa, U. and Eckhart, W. (1990) The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J., 9, 3253-3260.
70. Kohn, K.W. (1999) Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell, 10, 2703-2734.
71. Nakai, A., Suzuki, M. and Tanabe, M. (2000) Arrest of spermatogenesis in mice expressing an active heat shock transcription factor 1. EMBO J. 19, 1545-1554.
72. Vydra, N., Malusecka, E., Jarzab, M., Lisowska, K., Glowala-Kosinska, M., Benedyk, K., Widlak, P., Krawczyk, Z. and Widlak, W. (2006) Spermatocyte-specific expression of constitutively active heat shock factor 1 induces HSP70i-resistant apoptosis in male germ cells. Cell Death Differ., 13, 212-222.